GE HealthCare cuts 2025 adjusted EPS outlook to $3.90-$4.10 on tariffs despite Q1 growth
GE HealthCare reported first quarter 2025 revenue of $4.8 billion, up 3%, and diluted EPS of $1.23 versus $0.81 a year earlier. The company also cut its full-year 2025 guidance, including adjusted EPS of $3.90 to $4.10 versus prior guidance of $4.61 to $4.75, and said the outlook includes about $0.85 of tariff impact. The Board also authorized a $1 billion share repurchase program with no expiration date.
Key points
- Q1 2025 revenue $4.8 billion, up 3% reported and 4% organic; diluted EPS $1.23 versus $0.81; adjusted EPS $1.01 versus $0.90
- 2025 adjusted EPS guidance lowered to $3.90-$4.10 from $4.61-$4.75, including about $0.85 of tariff impact
- Free cash flow guidance lowered to at least $1.2 billion from at least $1.75 billion; Q1 free cash flow was $98 million versus $274 million
- Board authorized up to $1 billion in share repurchases with no expiration date
The filing
Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 30, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.